tiprankstipranks

Brian Adams Insider Profile

25 Followers
Brian Adams, CLO at Kymera Therapeutics, holds 50.25K shares in Kymera Therapeutics (Ticker: KYMR), holds 371.47K shares in Relay Therapeutics (Ticker: RLAY), holds 126.07K shares in Keryx Biopharma (Ticker: KERX). Most recently, Brian Adams Sold ― shares of Kymera Therapeutics on Sep 04, 2026 for an estimated value of $744.30K.
tipranks
Brian Adams

Brian Adams
Kymera Therapeutics (KYMR)
CLO

Ranked #18,588 out of 108,921 Corporate Insiders

Profitable Transactions

73%
40 out of 55 Profitable Transactions

Average Return

+2.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$13M
54.41%
45.59%
A breakdown of Brian Adams's holdings

Insider Roles

Relay Therapeutics
(RLAY)
CLO
Kymera Therapeutics
(KYMR)
CLO
Roles that Brian Adams holds in companies

Most Profitable Insider Trade

Stock:
Relay Therapeutics
(RLAY)
Rating:Informative Sell
Date:Nov 01, 2022 - Nov 01, 2023
Return:+69.50%
The most profitable trade made by Brian Adams

Brian Adams's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kymera Therapeutics
Sep 04, 2026
CLO
Informative Sell
744.30K
$5.88M
KERX
Keryx Biopharma
Feb 16, 2018
Informative Sell
27.19K
$423.59K
Relay Therapeutics
Jul 30, 2025
CLO
Informative Sell
73.38K
$7.02M
List of latest transactions for each holding click on a transaction to see Brian Adams's performance on stock

Brian Adams insider profile FAQ

What is the percentage of profitable transactions made by Brian Adams?
The percentage of profitable transactions made by Brian Adams is 73%.
    What is the average return per transaction made by Brian Adams?
    The average return per transaction made by Brian Adams is 2.60%.
      What stocks does Brian Adams hold?
      Brian Adams holds: KYMR, KERX, RLAY stocks.
        What was Brian Adams’s latest transaction?
        Brian Adams latest transaction was an Informative Sell of $744.30K.
          What was Brian Adams's most profitable transaction?
          Brian Adams’s most profitable transaction was an Informative Sell of RLAY stock on November 1, 2022. The return on the trade was 69.50%.
            What is Brian Adams's role in Kymera Therapeutics?
            Brian Adams's role in Kymera Therapeutics is CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.